Change over period: —
NSE · INDOBORAX
INDOBORAXC
-27.7% from the 52-week high · +57.1% above the low
Indo Borax & Chemicals Ltd. engages in the manufacturing and sale of chemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 98 full-time employees. Its products include borax, boric acid, and lithium hydroxide monohydrate. The Company’s borax products include borax decahydrate crystal and borax decahydrate granular; boric acid includes boric acid Indian Pharmacopoeia (IP) grade, boric acid tech grade granular and boric acid tech grade powder. Its product, borax decahydrate crystal, is used as fluxes and metallurgical operations (welding and brazing steel industry (paste fluxes, soldering fluxes). Its boric acid IP uses include eyewash, ointments, foot powder, shampoo, skin cream, mouthwash, and veterinary formulations. Its product, borax decahydrate granular, is used in fused products, such as glass, glass fiber ceramics, frits, glazed and porcelain enamels. Borax decahydrate crystal is also used in fertilizers as micronutrients. Its lithium hydroxide monohydrate is used in manufacturing lubricating greases.
The short version. INDOBORAXC reported revenue of ₹59 crore for Sep 2026, up 1.7% from a year earlier. Net profit was ₹5 crore (down 68.8% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 38.41% in Sep 2026, down 12.38 points over 8 quarters.
1 · The price
How has the stock traded?
INDOBORAXC trades 27.7% below its 52-week high and 57.1% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹59 cr.
Sep 2026 net profit of ₹5 cr.
20.0 pts lower than a year earlier.
Revenue compounded at -0.2% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | 70 | 63 | 41 | 58 | 54 | 50 | 38 |
| Net profit | 5 | 16 | 15 | 10 | 16 | 10 | 10 | 9 |
| Net margin % | 8.1 | 23.1 | 23.1 | 24.1 | 28.1 | 19.0 | 20.4 | 24.2 |
| EPS (₹) | 1.48 | 5.07 | 4.53 | 3.07 | 5.07 | 3.18 | 3.19 | 2.83 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 215 | 175 | 191 | 225 | 176 | 144 | 115 | 128 |
| Net profit | 50 | 43 | 39 | 51 | 36 | 34 | 17 | 18 |
| Net margin % | 23.3 | 24.3 | 20.4 | 22.5 | 20.7 | 23.8 | 14.7 | 13.7 |
| EPS (₹) | 15.67 | 13.25 | 12.15 | 15.8 | 11.33 | 10.68 | 5.28 | 5.46 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 13.0% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 13.0 | 12.7 | 13.3 | 19.9 |
| Return on capital % | 17.1 | 17.4 | 17.6 | 26.8 |
| EBITDA margin % | 30.2 | 32.2 | 26.9 | 30.4 |
| Net margin % | 21.8 | 22.3 | 19.2 | 21.8 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -0.2% | 9.3% |
| Profit CAGR | -0.3% | 8.0% |
4 · The owners
Who holds it, and are they adding?
Down 12.38 pts over 8 quarters.
Up 0.09 pts over 8 quarters.
Up 0.04 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.79 | 50.79 | 50.79 | 50.79 | 50.79 | 30.8 | 38.41 | 38.41 | -12.38 |
| FII | 0.01 | 0.02 | 0.02 | 0.53 | 0.23 | 0.45 | 0.13 | 0.1 | +0.09 |
| DII | 0 | 0.01 | 0.02 | 0.02 | 0.02 | 2.19 | 0.04 | 0.04 | +0.04 |
| Public | 49.2 | 49.17 | 49.16 | 48.66 | 48.96 | 66.56 | 61.42 | 61.44 | +12.24 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for INDOBORAXC are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about INDOBORAXC
What is the INDOBORAXC share price?
INDOBORAXC (INDOBORAX) last closed at ₹370.55, down 0.67% on the day. Its 52-week range is ₹237.53 to ₹516.05.
What is the market cap of INDOBORAXC?
INDOBORAXC has a market capitalisation of about ₹1,198 crore. Its price-to-earnings ratio is 26.8.
How are INDOBORAXC's latest results?
INDOBORAXC reported revenue of ₹59 crore for Sep 2026, up 1.7% from a year earlier. Net profit was ₹5 crore (down 68.8% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 38.41% in Sep 2026, down 12.38 points over 8 quarters.
Who owns INDOBORAXC?
As of Sep 2026, shareholding was: Promoter 38.41%, FII 0.1%, DII 0.04%, Public 61.44%.
How many mutual funds hold INDOBORAXC?
0 mutual fund schemes held INDOBORAXC in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 18 Sep 2025 · Final Dividend - Rs. 1
- 20 Aug 2024 · Final Dividend - Rs. 1
- 11 Aug 2023 · Dividend - Rs. 1
- 18 Aug 2022 · Final Dividend - Rs. 1
- 27 Sep 2021 · Stock Split From Rs.10/- to Rs.1/-
- 24 Aug 2021 · Final Dividend - Rs. 10
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.